High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism
Ebner, M.; Guddat, N.; Keller, K.; Merten, M. C.; Lerchbaumer, M. H.; Hasenfuß, G. & Konstantinides, S. V. et al. (2020)
ERJ Open Research, 6(4) pp. 00625-2020. DOI: https://doi.org/10.1183/23120541.00625-2020
Documents & Media
Details
- Authors
- Ebner, Matthias; Guddat, Niklas; Keller, Karsten; Merten, Marie Christine; Lerchbaumer, Markus H.; Hasenfuß, Gerd ; Konstantinides, Stavros V.; Lankeit, Mareike
- Abstract
- While numerous studies have confirmed the prognostic role of high-sensitivity troponin T (hsTnT) in pulmonary embolism (PE), high-sensitivity troponin I (hsTnI) is inappropriately studied. This study aimed to investigate the prognostic relevance of hsTnI in normotensive PE, establish the optimal cut-off value for risk stratification and to compare the prognostic performances of hsTnI and hsTnT. Based on data from 459 consecutive PE patients enrolled in a single-centre registry, receiver operating characteristic analysis was used to identify an optimal hsTnI cut-off value for prediction of in-hospital adverse outcomes (PE-related death, cardiopulmonary resuscitation or vasopressor treatment) and all-cause mortality. Patients who suffered an in-hospital adverse outcome (4.8%) had higher hsTnI concentrations compared with those with a favourable clinical course (57 (interquartile range (IQR) 22–197) versus 15 (IQR 10–86) pg·mL −1 , p=0.03). A hsTnI cut-off value of 16 ng·mL −1 provided optimal prognostic performance and predicted in-hospital adverse outcomes (OR 6.5, 95% CI 1.9–22.4) and all-cause mortality (OR 3.7, 95% CI 1.0–13.3). Between female and male patients, no relevant differences in hsTnI concentrations (17 (IQR 10–97) versus 17 (IQR 10–92) pg·mL −1 , p=0.79) or optimised cut-off values were observed. Risk stratification according to the 2019 European Society of Cardiology algorithm revealed no differences if calculated based on either hsTnI or hsTnT (p=0.68). Our findings confirm the prognostic role of hsTnI in normotensive PE. HsTnI concentrations >16 pg·mL −1 predicted in-hospital adverse outcome and all-cause mortality; sex-specific cut-off values do not seem necessary. Importantly, our results suggest that hsTnI and hsTnT can be used interchangeably for risk stratification.
- Issue Date
- 2020
- Journal
- ERJ Open Research
- eISSN
- 2312-0541
- Language
- English